Table of Contents
Cover image
As shown in these 2 patients with stage III NSCLC, change in total lesion glycolysis on serial 18F-FDG PET is predictive of response as early as 15 days into concomitant chemoradiotherapy. See page 1528.
As shown in these 2 patients with stage III NSCLC, change in total lesion glycolysis on serial 18F-FDG PET is predictive of response as early as 15 days into concomitant chemoradiotherapy. See page 1528.
